- Epitrochlear lymphadenopathy
-
Pannu AK, Prakash G, Jandial A, Kopp CR, Kumari S
- KMID: 2463499
- Korean J Intern Med.
- 2019 Nov;34(6):1396-1396.
- doi: 10.3904/kjim.2018.218
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A weeping ulcer that vanished with a ‘SMILE’
-
Jain A, Prakash G, Bal A, Malhotra P, Varma S
- KMID: 2414357
- Blood Res.
- 2018 Mar;53(1):8-8.
- doi: 10.5045/br.2018.53.1.8
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Diagnostic Dilemma of Neurolymphomatosis
-
Shree R, Goyal MK, Modi M, Gaspar BL, Radotra BD, Ahuja CK, Mittal BR, Prakash G
- KMID: 2354113
- J Clin Neurol.
- 2016 Jul;12(3):274-281.
- doi: 10.3988/jcn.2016.12.3.274
Neurolymphomatosis (NL) defined as infiltration of the central nervous system or the peripheral nervous system (PNS) by malignant lymphoma cells is a rare clinical entity. However, the increasing use of... -
- CITED
-
- Close
- SHARE
-
- Close
- Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience
-
Prakash G, Jain A, Sahu K, Bal A, Singh C, Basher R, Singh H, Mishra K, Jandial A, Lad D, Khadwal A, Srinivasan R, Das A, Varma N, Varma S, Malhotra P
- KMID: 2520582
- Blood Res.
- 2021 Sep;56(3):134-140.
- doi: 10.5045/br.2021.2021039
Background: This study evaluated the outcomes of patients with refractory/relapsed Hodgkin lymphoma (RRHL) treated with a bendamustine-based regimen in combination with ifosfamide, etoposide, and vinorelbine (VIBE). Methods: Consecutive RRHL patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature
-
Bommannan , Sachdeva M, Malhotra P, Kumar N, Sharma P, Naseem S, Ahluwalia , Das R, Varma N, Prakash G, Khadwal A, Srinivasan R, Varma S
- KMID: 2172741
- Blood Res.
- 2016 Mar;51(1):23-30.
- doi: 10.5045/br.2016.51.1.23
BACKGROUND: Plasma cell leukemia (PCL) is a rare and aggressive plasma cell neoplasm. In PCL, clonal plasma cells comprise ≥20% of the peripheral blood (PB) leukocytes and/or the absolute clonal... -
- CITED
-
- Close
- SHARE
-
- Close
